Medifast, Inc. (MED) Misses Q2 EPS by 9c
Tweet
Share
E-mailGet Alerts MED Hot Sheet
Price: $12.63 +0.72%
EPS Growth %: -195.2%
Financial Fact:
Selling, general, and administration: 43.21M
Today's EPS Names:
PMCB, CULP, HURC, More
EPS Growth %: -195.2%
Financial Fact:
Selling, general, and administration: 43.21M
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
Medifast, Inc. (NYSE: MED) reported Q2 EPS of $0.38, $0.09 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $78.3 million versus the consensus estimate of $81.83 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ambarella (AMBA) Tops Q2 EPS by 1c; offers guidance
- BRP Inc. (DOO) Reports Q2 Loss of Cd$0.18
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
